Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs RL✓SelectedUSD · RLGSK vs RL performance historyLatest closeAs of-1.56%11/19
Stock and ETF performance explorer

GSK vs RL

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+97.3%
RL return
+314.4%
Excess return
-217.1%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioRLExcessAlpha
1D-1.6%-1.9%+0.3%-1.4%
7D-4.7%-3.5%-1.2%-4.4%
30D-4.7%-0.4%-4.3%-4.7%
3M-8.8%0.0%-8.8%-8.8%
6M-4.6%+18.2%-22.8%-6.4%
YTD+1.0%+7.5%-6.5%-0.1%
1Y+6.9%+15.1%-8.3%+5.0%
3Y+52.5%+223.0%-170.5%+32.0%
5Y+40.3%+241.1%-200.8%+18.6%
All+97.3%+314.4%-217.1%+56.6%

Cumulative growth

Daily Returns

Daily percentage return beside RL.

Daily Out/Under-Performance

Portfolio return minus RL return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × RL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded RL wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling